This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Retinal Pioneers Programme

Bitesize OCT Knowledge Checkers

Test your OCT knowledge

Retinal Pioneers

Test your knowledge of optical coherence tomography (OCT) disease biomarkers in this series of OCT images and associated knowledge-checker questions provided by

Professor Richard Gale
, consultant ophthalmologist, York Teaching Hospitals NHS Foundation Trust. Can you identify all of the relevant biomarkers?

 

The knowledge checkers below have been developed for use on desktop computers.

SD-OCT USE IN MONITORING FOR HYDROXYCHLOROQUINE RETINOPATHY (NEW!)

Prescribing information for EYLEA® (aflibercept)

.

HOW USEFUL IS OCT-A FOR DMO?

Prescribing information for EYLEA® (aflibercept)

.

MANAGEMENT OF DMO

Prescribing information for EYLEA® (aflibercept)

.

DIAGNOSIS OF DMO

Prescribing information for EYLEA® (aflibercept)

.

DIFFERENTIAL DIAGNOSIS OF nAMD

Prescribing information for EYLEA® (aflibercept)

.

USING OCT TO RECOGNISE GA IN AMD

Prescribing information for EYLEA® (aflibercept)

.

IDENTIFYING DISEASE BIOMARKERS: HOW RELEVANT IS OCT-A?

Prescribing information for EYLEA® (aflibercept)

.

OCT BIOMARKERS OF DISEASE ACTIVITY IN nAMD

Prescribing information for EYLEA® (aflibercept)

.

PP-EYL-GB-2892 | August 2025